Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis
Selective CB 2 agonists represent an attractive therapeutic strategy for the treatment of a variety of diseases without psychiatric side effects mediated by the CB 1 receptor. We carried out a rational optimization of a black market designer drug SDB-001 that led to the identification of potent an...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
American Chemical Society
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/56683 |